However, the correlation of Her2/neu protein expression to the presence of TILs and TCRγ gene rearrangements in our group of ovarian carcinomas revealed that this is not the case, suggesting that other tumour antigens may be more promising candidate target antigens. Here, ERBB2 is linked to ovarian carcinoma.